Manufacturer record

Nest Healthcare Pvt.Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

4 batches manufactured by Nest Healthcare Pvt.Ltd (Gujarat) were declared Not of Standard Quality between May 2025 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

4 records linked to Nest Healthcare Pvt.Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
4Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, May 2025 to Jul 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

4
NSQ batches since 2025
4
Products affected
Other
Most common failure
Jul 2026
Latest alert

Flagged batches per year

2025 · 32026 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Methylprednisolone Tablets I.P. NHD24554AMfg 2024-11 · Exp 2026-10 The sample does not conform to IP with respect to the test for DissolutionDissolution CDTL, IndoreCDSCO lab Jul 2026
Metformin Hydrochloride Prolonged Release & Glimepiride Tablets IP,(Ajapride M2) NHD24148AMfg 2024-03 · Exp 2027-02 Sample fails the test Descriptive Part for the tablets as per IP.Other DTL Thiruvananthapuram,KeralaState lab Dec 2025
Atenolol Tablets IP 50 mg NHD25365AMfg 2025-05 · Exp 2027-04 ContentOther Drugs Testing Laboratory, Madurai-19State lab Oct 2025
Rabeprazole Sodium Enteric Coated & Domperidone Sustained Release Capsules (Kylid-RD) NHD24207CMfg 2024-05 · Exp 2026-04 The sample does not conform to the claim with respect to Assay of Rabeprazole Sodium.Assay DTL, Jaipur (State Lab)State lab May 2025

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.